Plans | Type(1) | Date of grant | Option exercise price (in euros) | Options outstanding at January 1, 2020 | Options cancelled, lapsed or transferred(2) in 2020 | Options exercised in 2020 | Options outstanding at December 31, 2020 | Of which exercisable at December 31, 2020 | Deadline | Remaining contract life (in years) |
|---|---|---|---|---|---|---|---|---|---|---|
Lionlead 3 2013-2016 France and outside France options | A | 04/30/2013 | 52.76 | 1,091,937 | (13,726) | - | 1,078,211 | 1,078,211 | 04/30/2023 | 2.33 |
Total of all tranches | 1,091,937 | (13,726) | 1,078,211 | 1,078,211 |
(1) A = stock options; S = share subscription options.
(2) These relate to any transfers between French and foreign plans due to the geographic mobility of beneficiaries.
The vesting period for the above plans has been completed, but the exercise of options remains subject to a continued presence condition until the date of exercise of the options.
2020 | 2019 | |||
|---|---|---|---|---|
| Number of options | Average exercise price (in euros) | Number of options | Average exercise price (in euros) | |
Options at January 1 | 1,091,937 | 52.76 | 1,206,242 | 52.76 |
Options exercised(1) | - | - | ||
Cancelled or lapsed options | (13,726) | 52.76 | (114,305) | 52.76 |
Options outstanding at December 31 | 1,078,211 | 52.76 | 1,091,937 | 52.76 |
Of which exercisable | 1,078,211 | 52,76 | 1,091,937 | 52,76 |
(1) Average share price on exercise (in euros) | n/a | 55.78 | ||
